Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Outpatient Management of Acute PE Remains Underused

Todd Neale

January 29, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

L.A. McKeown

October 06, 2023

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

L.A. McKeown

March 29, 2023

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News Daily News

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

Todd Neale

June 02, 2022

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

News Daily News

In-Hospital Stroke Requires a Rethink: AHA

Michael O'Riordan

February 09, 2022

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

Caitlin E. Cox

December 28, 2021

News Daily News

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Michael O'Riordan

November 29, 2021

News Daily News

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

Shelley Wood

June 22, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Outpatient Management of Acute PE Remains Underused

Experts Warn of Looming Private Equity Interest in Cardiology Care

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

In-Hospital Stroke Requires a Rethink: AHA

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

No Uptick in CVD Events After COVID-19 Vaccination in Older Adults

Antithrombotics No Help for Stable COVID-19 Outpatients: ACTIV-4b

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content